Tiger Pharmaceuticals (03347.HK) shareholder Cao Xiaochun collectively reduced their holdings by 347,600 shares.

Zhixin Finance APP News, Thai Ge Pharmaceuticals (03347.HK) announced that on November 18, 2025, the company received a notice from Ms. Cao Xiaochun, a shareholder, director, and general manager holding more than 5% of the shares, regarding the completion of the share reduction plan. As of November 18, 2025, Ms. Cao Xiaochun's share reduction plan had expired, during which she reduced a total of 347,600 shares, accounting for 0.0406% of the company's total share capital excluding shares in the repurchase account, and 0.0475% of the company's A-share total share capital.